These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16534857)

  • 1. Effect of oral naltrexone on pruritus in cholestatic patients.
    Mansour-Ghanaei F; Taheri A; Froutan H; Ghofrani H; Nasiri-Toosi M; Bagherzadeh AH; Farahvash MJ; Mirmomen S; Ebrahimi-Dariani N; Farhangi E; Pourrasouli Z
    World J Gastroenterol; 2006 Feb; 12(7):1125-8. PubMed ID: 16534857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study.
    Malekzad F; Arbabi M; Mohtasham N; Toosi P; Jaberian M; Mohajer M; Mohammadi MR; Roodsari MR; Nasiri S
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):948-50. PubMed ID: 19453814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study.
    Wolfhagen FH; Sternieri E; Hop WC; Vitale G; Bertolotti M; Van Buuren HR
    Gastroenterology; 1997 Oct; 113(4):1264-9. PubMed ID: 9322521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study.
    Terg R; Coronel E; Sordá J; Muñoz AE; Findor J
    J Hepatol; 2002 Dec; 37(6):717-22. PubMed ID: 12445410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis.
    Jones EA; Dekker LR
    Gastroenterology; 2000 Feb; 118(2):431-2. PubMed ID: 10648471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study.
    Pauli-Magnus C; Mikus G; Alscher DM; Kirschner T; Nagel W; Gugeler N; Risler T; Berger ED; Kuhlmann U; Mettang T
    J Am Soc Nephrol; 2000 Mar; 11(3):514-519. PubMed ID: 10703675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-label trial of oral nalmefene therapy for the pruritus of cholestasis.
    Bergasa NV; Schmitt JM; Talbot TL; Alling DW; Swain MG; Turner ML; Jenkins JB; Jones EA
    Hepatology; 1998 Mar; 27(3):679-84. PubMed ID: 9500694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of oral naltrexone for severe pruritus due to cholestatic liver disease in children.
    Zellos A; Roy A; Schwarz KB
    J Pediatr Gastroenterol Nutr; 2010 Dec; 51(6):787-9. PubMed ID: 20948447
    [No Abstract]   [Full Text] [Related]  

  • 9. [Opiod antagonists and treatment of cholestatic pruritus].
    Sapey T
    Gastroenterol Clin Biol; 1998 Feb; 22(2):255-6. PubMed ID: 9762206
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative study on the effects of naltrexone and loratadine on uremic pruritus.
    Legroux-Crespel E; Clèdes J; Misery L
    Dermatology; 2004; 208(4):326-30. PubMed ID: 15178915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study.
    Bergasa NV; Alling DW; Talbot TL; Wells MC; Jones EA
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):431-4. PubMed ID: 10459118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases.
    Metze D; Reimann S; Beissert S; Luger T
    J Am Acad Dermatol; 1999 Oct; 41(4):533-9. PubMed ID: 10495371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone for cholestatic itch: a systematic review.
    Murray-Brown FL
    BMJ Support Palliat Care; 2021 Jun; 11(2):217-225. PubMed ID: 33692114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of naltrexone in the management of severe generalized pruritus in biliary atresia: report of a case.
    Chang Y; Golkar L
    Pediatr Dermatol; 2008; 25(3):403-4. PubMed ID: 18577062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non-placebo controlled administration in 133 patients].
    Brune A; Metze D; Luger TA; Ständer S
    Hautarzt; 2004 Dec; 55(12):1130-6. PubMed ID: 15517116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: results of a double-blind, randomized, placebo-controlled trial.
    Kuiper EM; van Erpecum KJ; Beuers U; Hansen BE; Thio HB; de Man RA; Janssen HL; van Buuren HR
    Hepatology; 2010 Oct; 52(4):1334-40. PubMed ID: 20683930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of the use of naltrexone to treat the severe pruritus of cholestatic liver disease.
    Carson KL; Tran TT; Cotton P; Sharara AI; Hunt CM
    Am J Gastroenterol; 1996 May; 91(5):1022-3. PubMed ID: 8633543
    [No Abstract]   [Full Text] [Related]  

  • 18. Liver transplantation for intractable pruritus is contraindicated before an adequate trial of opiate antagonist therapy.
    Neuberger J; Jones EA
    Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1393-4. PubMed ID: 11692070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opiate receptor antagonists for treatment of severe pruritus associated with advanced cholestatic liver disease.
    Kumar N; Garg N; Bailey A
    J Palliat Med; 2013 Feb; 16(2):122-3. PubMed ID: 23391399
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomised crossover trial of naltrexone in uraemic pruritus.
    Peer G; Kivity S; Agami O; Fireman E; Silverberg D; Blum M; laina A
    Lancet; 1996 Dec; 348(9041):1552-4. PubMed ID: 8950882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.